: :inin Kyiv (EET)

US biotechs to speed work on Nipah vaccine even as health ministry denies major outbreak


A global coalition set up a year ago to fight epidemics has struck a $25 million deal with two U.S. biotech companies to accelerate work on a vaccine against the brain-damaging Nipah virus that has killed 12 people in India.
The Coalition for Epidemic Preparedness Innovations (CEPI) said on Thursday that Profectus BioSciences and Emergent BioSolutions would receive up to $25 million to advance development and manufacturing of a shot for the bat-borne disease.
There is currently no vaccine or treatment to tackle Nipah, which has a mortality rate of around 70 percent.
The death toll from the latest outbreak in Kerala rose …read more

Source: Daily News & Analysis

World press about Ukraine

This website is created to observe information about Ukraine in the world media. More information about press.uaposition.com you can read here

World press category: terms & conditions